Aspirin can reduce potential for dying from bowel malignancy by 30 percent Taking aspirin after becoming identified as having bowel cancer can reduce the potential for dying from the condition by 30 percent, new research shows today. The study, released in the British Journal of Malignancy, discovered that bowel cancer patients who had taken a daily dosage of aspirin for at least nine weeks after their diagnosis had cut their chance of dying from the disease by 30 percent. Researchers added that bowel tumor sufferers who got aspirin for any length of time post-medical diagnosis had a 23 per cent less chance of dying from bowel tumor compared with patients who had taken no aspirin at all. Bowel cancer may be the third most common tumor in the united kingdom – with around 41,000 new cases of the condition a year.Rago provides since graduated from Brown, and Dean, an M.D.-Ph.D. Student, has moved on from the Morgan laboratory to pursue his surgical rotations.
Caregivers are not choosing low priced plan option, says new study A new research from Caring.com has revealed in least a third of it is members are caring for aging parents or family members enrolled in a Medicare Component D prescription drug program and among this group, only half know about how and where you can enroll in this program and not even half are aware of what it addresses.